Status
Conditions
Treatments
About
In patients clinically treated with FDA-approved immunotherapy the investigators will assess the predictive value of pre- and on-treatment 1) immune-methylation profiling across cancer types, and 2) immune-methylation profiling and cytokine profiling within cancer types.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,500 participants in 3 patient groups
Loading...
Central trial contact
Hannah G Stolrow, BA; Brock C Christensen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal